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Parkinson’s disease affects over one million
people in the United States. Although there have
been  remarkable  advances  in  uncovering  the
pathogenesis of this disabling disorder, the etiol-
ogy is speculative. Medical treatment and opera-
tive procedures provide symptomatic relief only.
Compression  of  the  cerebral  peduncle  of  the
midbrain by the posterior cerebral artery in a
patient with Parkinson’s Disease (Parkinson’s
Disease)  was  noted  on  magnetic  resonance
imaging  (MRI)  scan  and  at  operation  in  a
patient with trigeminal neuralgia. Following the
vascular decompression of the trigeminal nerve,
the midbrain was decompressed by mobilizing
and repositioning the posterior cerebral artery
The  patient's  Parkinson's  signs  disappeared
over a 48-hour period. They returned 18 months
later with contralateral peduncle compression. A
blinded evaluation of MRI scans of Parkinson's
patients and controls was performed. MRI scans
in 20 Parkinson's patients and 20 age and sex
matched controls were evaluated in blinded fash-
ion looking for the presence and degree of arte-
rial compression of the cerebral peduncle. The
MRI  study  showed  that  73.7  percent  of
Parkinson's Disease patients had visible arterial
compression of the cerebral peduncle. This was
seen in only 10 percent of control patients (two
patients, one of whom subsequently developed
Parkinson’s Disease); thus 5 percent. Vascular
compression of the cerebral peduncle by the pos-
terior  cerebral  artery  may  be  associated  with
Parkinson’s Disease in some patients. Microva  -
scular decompression of that artery away from
the peduncle may be considered for treatment of
Parkinson’s Disease in some patients.
Introduction
The pathogenesis of Parkinson’s Disease is
unclear.1,2 The loss of pigmented neurons in
substantia  nigra,  locus  ceruleus,  and  brain-
stem  nuclei  is  found  in  most  forms  of
Parkinson’s Disease. Depletion of the neuro-
transmitter  substance  Dopamine  has  been
demonstrated in experimental animals and in
humans.  Etiologic  mechanisms  have  been
attributed  to  MPTP  exposure,  environmental
neurotoxins,  trauma,  endogenous  neurotox-
ins, genetic predisposition and genetic associ-
ations with a variety of mutations, oxidative
stress and apoptosis. By clinical observation,
one  of  us  (PJ)  noted  magnetic  resonance
imaging  (MRI)  compression  of  the  cerebral
peduncle by the posterior cerebral artery on
MRI  scan  in  a  patient  with  Parkinson’s
Disease and treated it. This encouraged us to
perform a blinded study of MRI scans in age
and sex matched Parkinson disease cases and
control patients. 
Materials and Methods
A  60-year-old  woman  had  intractable  left
sided trigeminal neuralgia. She also had well-
documented  Parkinson’s  Disease.  After
microvascular decompression (MVD) of the left
trigeminal nerve, MVD of the left anterolateral
midbrain was performed. Based upon the MRI
and  intraoperative  findings  in  the  above
patient, a blinded MRI study of 40 MRI scans, 20
with known Parkinson’s Disease and 20 con-
trols, was performed under the purview of an
IRB  approved  protocol.  Twenty  MRI  scans  in
patients with Parkinson’s Disease and 20 age
and sex matched control MRI scans were evalu-
ated in a blinded randomized fashion by two
groups  of  two  investigators  (PJ/DW  and
MF/RW). The Parkinson’s Disease patients had
been  seen  and  followed  in  our  Parkinson’s
Disease  clinic  with  the  diagnosis  well  estab-
lished  by  clinical  criteria.  The  study  was
approved by our IRB. The T2 study of the mid-
brain was evaluated in all patients. The T2 axial
views of the midbrain were independently eval-
uated and interviewer discrepancies (only two
in number) were aligned. Arterial compression-
distortion of the cerebral peduncles was graded
as follows: grade 0, no compression; grade 1,
compression  only;  grade  2,  compression  and
distortion of the midbrain. The offending artery
was the posterior cerebral artery in every case.
Case Report
A  60-year-old  woman  was  seen  in  the
Jannetta Cranial Nerve Center, Department of
Neurosurgery,  Allegheny  General  Hospital,
with the chief complaint of left facial pain of 11
years duration, which was lancinating, inter-
mittent, and located in the left V3 distribution.
This pain was exacerbated by the usual factors.
The  diagnosis  of  trigeminal  neuralgia  was
made.  She  had  taken  increasing  doses  of
phenytoin,  baclofen,  gabapentin,  and  carba-
mazepine, all of which had to be discontinued
because of a lack of relief or side effects. Past
medical history showed type 2 diabetes, and one
transient  ischemic  attack.  The  diagnosis  of
Parkinson’s  Disease  had  been  established  2
years prior to admission based on progressively
severe resting tremor of the upper extremities,
mask-like facies, postural instability, and cog-
wheel rigidity. The family history was non-con-
tributory. Her medications included metformin
for the DM2, carbamazepine for facial pain and
amantadine for parkinsonism in a dose of 100
mg. b.i.d. She had been on carbidopa-levodopa
to which she became intolerant. She was seen
in consultation regarding operative treatment
of her intractable trigeminal neuralgia. Physical
examination showed a 60-year-old woman who
had a prominent stare, mask-like facies, cog-
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[page 24] [Neurology International 2011; 3:e7]wheel rigidity of the upper extremities and an
intermittent pill rolling type of tremor of the
upper extremities. Her posture was stooped and
gait showed small, uncertain steps with a ten-
dency for festination. Neurological examination
was otherwise normal. Specifically, the corneal
reflexes, both upper and lower, were brisk and
equal. Sensory and motor examination of the
trigeminal  nerve  was  normal.  The  diagnoses
included: i) Intractable trigeminal neuralgia in
the left V3 distribution; ii) Parkinson’s Disease
treated with amantadine; iii) Type 2 diabetes
mellitus treated with metformin.
Special studies
Magnetic  resonance  imaging  of  the  brain
was reported as normal. One of us (PJ) noted
that the left posterior cerebral artery was com-
pressing and distorting the left cerebral pedun-
cle  (Figure  1).  After  discussion  with  the
patient  and  her  husband,  it  was  decided  to
evaluate and treat the compression of the mid-
brain, if feasible, after microvascular decom-
pression of the trigeminal nerve. 
Operation
With the patient under general endotracheal
anesthesia in the right lateral decubitus posi-
tion  a  left  retromastoid  craniectomy  and
microvascular decompression of the trigemi-
nal nerve was performed using techniques pre-
viously described.3 The anterolateral midbrain
was then exposed by angling the microscope
rostrally. The posterior cerebral artery groov-
ing the midbrain (Figure 2) was mobilized and
held  away  with  an  implant  of  soft  shredded
Teflon  felt  (Figure  3).  The  wound  was  then
closed in the usual manner.
Results
The  postoperative  course  was  benign.  The
patient awoke with the face pain relieved and
without the mask-like facies. The cogwheeling
rigidity was gone by the first postoperative day.
There was no tremor at any time. She was dis-
charged from the hospital on the second postop-
erative day. When seen on the fifth postopera-
tive day, she was pain free and without signs of
parkinsonism. She remained well for 18 months
and then suffered recurrence. MRI scan now
showed compression of the contralateral cere-
bral peduncle by the PCA (Figure 4). 
Magnetic resonance imaging study
The MRI study was deemed inadequate in
one  Parkinson’s  Disease  patient.  Of  the  19
Parkinson’s  Disease  patients,  13  had  clear
compression-distortion of one or both of the
cerebral  peduncles  by  the  posterior  cerebral
artery (78%). Four were bilateral. Seven were
Grade 2. Of the 20 control patients, only 2 had
compression  of  the  cerebral  peduncle,  each
with a Grade 1. One of these two patients was
later  diagnosed  with  Parkinson’s  Disease.
Three patients had questionable compression.
The  other  control  scans  showed  no  arterial
compression-distortion  of  the  peduncle.
(Figure 5) These data are collated in Tables 1
and 2. Figure 6 shows bilateral compression in
a  Parkinson’s  Disease  patient.  Statistical
Article
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Figure 1. Magnetic resonance imaging scan
T2 axial view at level of midbrain. Arrow
points to area of compression of left cere-
bral peduncle by posterior cerebral artery.
Clear space filled with cerebral fluid is seen
on the right.
Figure 2. View through microscope of left
cerebral  peduncle  in  patient  with
Parkinson’s Disease. Arrow points to PCA
partly buried in the midbrain.
Figure 3. Same view as Figure 2. Artery has
been  mobilized  away  from  the  cerebral
peduncle  and  decompressed  using  shred-
ded PTFE felt. 
Figure 4. Magnetic resonance imaging  T2
axial  view  two  years  postoperatively.
Recurrence began about 18 months post-
operatively.  Left  caudal  peduncle  shows
implant  separating  PCA  (three  arrows).
Right  cerebral  peduncle  now  compressed
by PCA (two arrows).
Figure 5. Magnetic resonance imaging  T2
axial view at the level of midbrain in con-
trol  patient  without  Parkinson  Disease.
Note that posterior cerebral arteries do not
impinge  upon  cerebral  peduncle.  A  clear
space filled with cerebrospinal fluid is seen
bilaterally. 
Figure 6. Magnetic resonance imaging  T2
Axial  view.  Bilateral  compression  in
patients with Parkinson Disease.analysis was performed utilizing MedCalc for
PC 9.6.4.0. A forward logistic regression was
performed with the diagnosis of Parkinson’s
Disease as the dependent variable and age, sex
and maximum degree of vascular compression
on either side as covariates. 
There  was  a  significant  relationship
between  a  diagnosis  of  Parkinson’s  Disease
and maximal degree of radiographic vascular
compression  (P=.006),  OR  9.0  (95%  CI  1.9-
43.1), with 78% of cases correctly classified.
Although the overall distribution of extent of
compression was nearly identical when com-
paring each side (Chi-square 1.63, P=.65) the
correlation of degree of compression in each
individual was low (kappa = .2).
Discussion
Beginning  in  1966,  a  growing  number  of
cranial nerve and brainstem syndromes have
been reported to be caused by pulsatile vascu-
lar  compression,  arterial  or  venous  or  both.
These include such apparently disparate prob-
lems as trigeminal neuralgia3-5 (both typical
and atypical), hemifacial spasm,6,7 Meniere’s
disease,8 disabling  positional  vertigo,9 glos-
sopharyngeal  neuralgia,10-12 Bell’s  palsy,13
essential  hypertension14-17 and  type  2  dia-
betes.18,19 This knowledge of the above enti-
ties, although known and accepted in the neu-
rosurgical  community,  have  not  penetrated
into  the  general  medicine  literature.
Beginning in the same year (1966), treatment
of  the  pulsatile  compression  (microvascular
decompression)  was  developed.  These  find-
ings and treatments were possible because of
the use of then new technology, and the mag-
nification, lighting and recording capabilities
of the surgical binocular microscope.13-19
It is estimated that over one million people
in the United States have Parkinsonism from
various causes. The incidence increases with
advanced age, although it is known that young
people may develop a rapidly advancing form of
Parkinson’s  Disease.  The  true  etiology  of
Parkinson’s Disease has been unclear, but it is
well  recognized  that  loss  of  pigmented  neu-
rons,  especially  the  substantia  nigra,  locus
ceruleus, and brainstem nuclei is found in vir-
tually  all  forms.  Many  careful  investigators
have stated that they do not know the etiology
and have called Parkinson’s Disease idiopath-
ic, i.e., the true primary etiology is unknown.
The loss of pigmented neurons is associated
with the presence of Lewy bodies in the basal
ganglia  and  upper  brainstem.  Pathogenic
mechanisms have been related to MPTP expo-
sure, environmental neurotoxins, trauma, the
enigmatic neuroprotective effect of smoking,
endogenous neurotoxins, and genetic factors. 
One reason that arterial compression of the
cerebral  peduncle  was  never  noted  may  be
because of the technique of the standard post
mortem examination of the brain. For the post
mortem exam, the calvarium is removed with a
power saw. The dura mater is removed. The
forebrain is then raised up off the frontal-tem-
poral  fossa  and  the  region  of  the  midbrain
transected using a scalpel or scissors. This, the
area of the vascular compression, is unfortu-
nately stretched, distorted and at times tran-
sected. Subtle neurovascular relationships are
lost. The autopsy technique of removal of the
hindbrain also has denied careful study of neu-
rovascular  relationships  of  the  pons  and
medulla even if the brain has been removed in
one piece. In any case, arterial relationships
have generally been found by pathologists.
The  pathophysiology  of  pulsatile  compres-
sion  of  the  cerebral  peduncles  may  be  the
same as vascular compression of the cranial
nerves  and  medulla  oblongata.  Severe  com-
pression of central nervous tissue causes rapid
or severe loss of function. This is seen in Bells
Article
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Table 1. Parkinson disease: compression of cerebral peduncle by posterior cerebral artery.
Parkinson Disease  Arterial compression Control group n=20
(Parkinson’s disease) 
Group n=19
ID # Right Left Sex Age Grading Scale ID # Right Left Sex Age
1 1 ?2 2F 64 0  No Contact 20 0M 56
40 2 F 67 1  Contact 30 0M 58
6? 1 M 57 2  Distortion 50 0M 58
70 0 F 69 ? Possible contact 80 0M 59
90 0 M 59 11 00 M 61
10 ?0M 71 Parkinson’s disease female mean age 12 ?0 M 62
13 00M 62 66.625 14 00 M 63
16 10F 82 15 00 M 63
17 00M 72 Parkinson’s disease male mean age 19 00 M 64
18 01M 62 61.727 20 00 M 70
21 10F 81 22 ?0 F 57
23 01M 59 Control female mean age 24 00 F 57
26 20M 68 62.6 25 00 F 57
27 20F 67 29 10 F 59
28 12F 50 Control male mean age 30 00 F 59
31 ?1M 50 61.4 33 ?0 F 63
32 12F 53 34 00 F 66
35 21M 59 Parkinson’s disease & controls mean age 36 00 F 67
39 00M 60 62.871 38 0? F 70
40 11 F 71
Parkinson’s disease patients vs. controls. Side, frequency, and degree (Grade) of  arterial compression. 0 = No contact of artery on cerebral peduncle. 1 = Artery is touching cerebral peduncle. 2 = Artery is com-
pressing cerebral peduncle to cause distortion. ? = Scan not clear enough to determine if artery touching cerebral peduncle or not.
Table  2.  Parkinson’s  disease.  data  collated  –  parkinson’s  disease  patients  and  control
patients.
Grade 0% 1 or 2 %? %
PD n=19 5 26.3 13 68.4 1 5.3
C n=20 14 70 2 10 4 20
Parkinson disease: arterial compression of Midbrain. Grading scale: 0 No Contact; 1 Contact; 2 Distortion; ? Possible Contact/Distortion.
Note: one of 2 patients with compression subsequently developed Parkinson’s disease. palsy when a shifting artery, usually the ante-
rior  inferior  cerebellar  artery  stretches  and
compresses the facial (and to a lesser degree)
the auditory nerve.13 Fortunately, this physical-
ly  tough  motor  nerve  usually  (80  percent)
recovers function in time. Modest and progres-
sive pulsatile compression, on the other hand,
causes hyperactive symptoms, a caricature of
the normal function of the nerve, (i.e., sensa-
tion --- pain, motor function --- twitching and
spasm).  As  it  progresses,  loss  of  function
occurs, (i.e., numbness, weakness). ultrastruc-
tural changes of hypermyelination, hypomyeli-
nation, kissing axis cylinders, dead, dying and
regenerating  axis  cylinders  are  seen  spread
over  a  background  of  normal  axons  and
myelin.20-22 The loss of substantia nigra cells
and coloration may be a part of this process.
This of course is a later stage of the disease
seen  at  post  mortem  exam  while  the  ultra-
structural changes in the cranial nerves are
from  operative  specimens.  These  changes
reflect a dynamic and progressive process of
hyperactivity and the loss of function. Ephaptic
transmission and kindling may each play an
important role.23,24
Medical and operative treatment consists of
dopamine agonists and the replacement of MAO
and COMT inhibition and operative interven-
tion with brainstem lesions and stimulation.25-
27 In virtually all cases the disease progresses
despite therapeutic intervention. Various stud-
ies including glial-derived nerve growth factor,
and many medications and possible operative
intervention are currently in process.
The present data raise questions regarding
etiology which may be answered over time: i.e.,
Does  unilateral  cerebral  peduncle  arterial
compression  cause  unilateral  disease  only?
Can it cause bilateral Parkinson’s Disease in
time? Can MVD relieve parkinsonism? Is there
a form of parkinsonism related to arterial com-
pression  of  the  cerebral  peduncle?  Is
Parkinson’s Disease in young people the same
etiologically  as  in  the  older  population?  Are
Cognitive changes reversible? Will MVD of the
cerebral peduncle be as safe and effective as
MVD is for other problems? 
A multi center MRI trial has been organized
for  further  evaluation  of  this  concept.
Microvascular decompression of the brainstem
should be performed only by specially prepared
neurosurgeons  with  a  background  in
microvascular decompression and training by
the senior author.
On the basis of these data, some cases of
Parkinsonism may be associated with arterial
compression of the cerebral peduncle by the
posterior cerebral artery which may frequently
be seen on MRI studies. Improvement and pro-
longed  relief  of  Parkinson’s  Disease  in  one
patient demonstrates that relief of Parkinson’s
Disease  may  be  possible  in  certain  circum-
stances. 
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